The Chair’s Perspective

Dear Friends and Colleagues,

“She made it clear they would not stop until they figured it out.”

That’s how a patient profiled in this report recounts the relentless determination of his Kellogg opththalmologist and her colleagues from across Michigan Medicine to decode his perplexing symptoms in order to provide life-saving treatment. Every day our Kellogg physicians, residents, fellows and staff work to earn our reputation as a team that never backs down from ophthalmology’s challenges.

In this year’s Annual Report, we share stories that highlight how our guiding principles of innovation, teamwork, inclusion, caring, and integrity direct our care and shape our commitment to creating tomorrow’s new treatments, including:

• Expanded treatment options, from living donor corneal limbal stem cell transplants to over 50 active clinical trials and more. • Our development of groundbreaking new biomedical tools, such as a minimally-invasive ‘nanoneedle’ platform for painless, sustained intraocular drug delivery, and photo-mediated ultrasound- a potentially safer, more precise method of remov- ing tiny retinal blood vessels.

• The grant-funded work of Kellogg’s basic, clinical and transla- tional researchers to identify new therapeutic targets for conditions including choroideremia, nanophthalmos, inherited retinal degenerations, and proliferative vitreoretinopathy.

• Faculty dedicated to eliminating disparities in visual health, including the development and implementation of a personalized intervention among residents of Detroit.

• Kellogg’s sustained commitment to training tomorrow’s ophthalmology leaders in wide-ranging areas such as a new neural engineering training program in Ann Arbor, an NIH- funded program to train eye disease researchers in India, and a pediatric ophthalmology fellowship in Ghana.

• Kellogg alumni and supporters who are critical partners in our success, providing expertise, wisdom and resources for our efforts.

Throughout the challenges of this past year and a half, the resiliency, tenacity, and hard work of everyone at Kellogg has been central to our continuing success. We are grateful for the opportunity we have every day to improve the lives of our patients, communities, and our Kellogg teammates. We thank you for your encouragement and support.

Paul P. Lee, M.D., J.D.

F. Bruce Fralick Professor and

Chair, Ophthalmology and Visual Sciences

Director, W.K. Kellogg Eye Center